Sign In
Buy INCY
$97.98
+5.74 (+6.22%)
At Close: Jun 03, 2026
Wall Street : Perd pied avec la pandémie, négatif sur juin
09:43pm, Friday, 26'th Jun 2020
(CercleFinance.com) - Wall Street subit une brusque correction qui a pris beaucoup d'opérateurs par surprise: ils s'étaient habitués à ce que les marchés …
Gilead's (GILD) Remdesivir Gets CHMP Approval Recommendation
02:37pm, Friday, 26'th Jun 2020
Gilead's (GILD) experimental coronavirus drug, remdesivir, has been recommended for approval by the EMA's human medicines committee.
MODERNA :signe un contrat de conditionnement de son vaccin avec Catalent | Zone bourse
12:31pm, Thursday, 25'th Jun 2020Maria E. Pasquale Sells 1,423 Shares of Incyte Co. (NASDAQ:INCY) Stock
06:45am, Thursday, 25'th Jun 2020
Incyte Co. (NASDAQ:INCY) EVP Maria E. Pasquale sold 1,423 shares of the business’s stock in a transaction dated Friday, June 19th. The stock was sold at an average price of $100.00, for a total tran
Incyte (NASDAQ:INCY) Shares Up 3.2%
05:38am, Wednesday, 24'th Jun 2020
Incyte Co. (NASDAQ:INCY)’s share price was up 3.2% on Monday . The company traded as high as $106.26 and last traded at $108.76, approximately 110,450 shares were traded during mid-day trading. A de
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 23)
ACADIA Pharmaceuticals Inc...
Gilead to Start Studies for an Inhaled Version of Remdesivir
02:24pm, Tuesday, 23'rd Jun 2020
Gilead (GILD) announces plans to start studies for an inhaled version of the experimental candidate, remdesivir, in August.
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Wall Street : Entame de T3 bullish et record pour le Nasdaq
09:58pm, Monday, 22'nd Jun 2020
(CercleFinance.com) - Le 3ème trimestre démarrage pour les chapeaux de roues pour le Nasdaq (+1,1%) qui inscrit un nouveau record absolu de clôture à …
Nasdaq's Excels in Weekly Performance: 5 Best Stocks in ETF
04:05pm, Monday, 22'nd Jun 2020
In a tug of war between bulls and bears, the Dow Jones and S&P; 500 gained at least 1% each last week while the Nasdaq Composite Index advanced over 3%.
Gilead's stock falls as it announces clinical trial for inhaled remdesivir
01:34pm, Monday, 22'nd Jun 2020
Shares of Gilead Sciences Inc. undefined were down 1.2% in trading on Monday after the drugmaker said it plans to start Phase 1 clinical trials for an...
Gilead's stock falls as it announces clinical trial for inhaled remdesivir
01:34pm, Monday, 22'nd Jun 2020
Shares of Gilead Sciences Inc. were down 1.2% in trading on Monday after the drugmaker said it plans to start Phase 1 clinical trials for an inhaled version of remdesivir, its treatment for severely
Incyte (INCY) Looks Good: Stock Adds 8.3% in Session
12:36pm, Monday, 22'nd Jun 2020
Incyte (INCY) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
Nasdaq's Excels in Weekly Performance: 5 Best Stocks in ETF
12:05pm, Monday, 22'nd Jun 2020
In a tug of war between bulls and bears, the Dow Jones and S&P 500 gained at least 1% each last week while the Nasdaq Composite Index advanced over 3%.
Incyte (INCY) Looks Good: Stock Adds 8.3% in Session
08:36am, Monday, 22'nd Jun 2020
Incyte (INCY) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.
